Pharmaceutical development and specification of stereoisomers

J Pharm Biomed Anal. 1998 Sep 1;17(6-7):917-24. doi: 10.1016/s0731-7085(98)00059-4.

Abstract

The pharmaceutical development of chiral drugs requires the activities of many different research and development groups. Guidelines which help to coordinate the activities of these groups and assist in the successful development of compounds with either single or multiple chiral centers are outlined and discussed.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Drug Evaluation / methods
  • Drug Evaluation / standards*
  • Guidelines as Topic / standards*
  • Humans
  • Stereoisomerism*
  • Terminology as Topic